Navigation Links
Transcept Pharmaceuticals to Report Second Quarter 2009 Results
Date:8/6/2009

RICHMOND, Calif., Aug. 6 /PRNewswire-FirstCall/ -- Transcept Pharmaceuticals, Inc. (Nasdaq: TSPT), a specialty pharmaceutical company focused on the development and commercialization of proprietary products that address important therapeutic needs in the field of neuroscience, today announced it will report results for its quarter ended June 30, 2009 on Friday, August 14, 2009, prior to the opening of the market.

A conference call to review the results will begin at 8:30 a.m. ET (5:30 a.m. PT) on August 14, 2009 and will be hosted by Glenn A. Oclassen, President & Chief Executive Officer, and Thomas P. Soloway, Senior Vice President & Chief Financial Officer.

To participate in the conference call, please dial 877-397-0284 (USA) or 719-325-4890 (International). In addition, a dial-up replay of the conference call will be available from August 14, 2009 through August 26, 2009. The replay telephone number is 888-203-1112 (USA) or 719-457-0820 (International), Replay Passcode: 2582954.

A live webcast of the call will also be available from the Investors section on the corporate web site at www.transcept.com. A webcast replay can be accessed on the corporate web site beginning August 14, 2009 at the same time as the conference call and will remain on the site through August 28, 2009.

About Intermezzo(R)

Intermezzo(R) (zolpidem tartrate sublingual tablet), the lead product candidate at Transcept, has the potential to be the first prescription sleep aid specifically approved for use in the middle of the night at the time a patient awakens and has difficulty returning to sleep. Intermezzo(R) is a sublingual low dose formulation of zolpidem, the active agent most commonly prescribed in the Un
'/>"/>

SOURCE Transcept Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Transcept Pharmaceuticals to Hold Conference Call on Agreement with Purdue Pharmaceutical Products L.P. to Commercialize Intermezzo(R) in the United States
2. Transcept Pharmaceuticals to Present at BMO Capital Markets Healthcare Conference on August 5, 2009
3. Transcept Pharmaceuticals Announces Expected FDA Extension of Regulatory Review Period for Intermezzo(R)
4. Transcept Pharmaceuticals to Present at Needham Life Sciences Conference on June 10, 2009
5. Transcept Pharmaceuticals Presents Data from Studies of Two Product Candidates at Annual Meeting of the American Psychiatric Association
6. Transcept Pharmaceuticals Reports First Quarter 2009 Financial Results
7. Transcept Pharmaceuticals Appoints Joseph T. Kennedy as General Counsel
8. Transcept Pharmaceuticals Reports Fourth Quarter and Year End 2008 Financial Results
9. Transcept Pharmaceuticals to Report Fourth Quarter 2008 Results
10. Transcept Pharmaceuticals to Present at Two Upcoming Conferences
11. Transcept Pharmaceuticals, Inc. Completes Merger with Novacea, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/3/2014)... Diego, CA (PRWEB) September 03, 2014 AttorneyOne.com, ... all the latest information from the FDA on Pedigree ... on August 26, that 22 bags of Pedigree Adult Complete ... to the possible presence of a foreign material. The reason ... metal fragments, which could have entered the packages during the ...
(Date:9/3/2014)... While the Affordable Care Act provides ... the goal of offering better quality care at ... increasing scrutiny of hospital-physician transactions to ensure they ... This increased scrutiny resulted in the first-ever antitrust ... physician practice earlier this year. , ...
(Date:9/3/2014)... LabRoots announces a new educational webinar ... in Translational Diagnostics: Mining and Migrating Robust Cancer ... be airing live September 10, 2014 1:00pm Eastern Time. ... NGS-based biomarker discovery will be introduced, as ... these markers to targeted NGS assays using low-quality (FFPE) ...
(Date:9/3/2014)... (PRWEB) September 03, 2014 Health ... increases patient safety, decreases medical errors, and strengthens ... , To mark the important role health information ... IHS and others across the U.S. have joined ... Week , September 16-20, 2014. With the NHIT ...
(Date:9/3/2014)... 03, 2014 Job seekers who are ... next position can now do both on iHire. By ... a seamless tool for investigating employment and educational opportunities ... online courses) are closing skills gaps and challenging the ... degree programs and brick and mortar universities. To make ...
Breaking Medicine News(10 mins):Health News:Pedigree Adult Complete Nutrition for Dogs Recalled: AttorneyOne Monitors and Keeps Consumers Informed 2Health News:Recent Becker’s Article Addresses Antitrust and Hospital Acquisition of Physician Practices 2Health News:LabRoots Announces New Educational Webinar on Next-Generation Sequencing 2Health News:LabRoots Announces New Educational Webinar on Next-Generation Sequencing 3Health News:Innovative Healthcare Solutions (IHS) Celebrates National Health IT Week September, 15-19, 2014 2Health News:iHire Announces Partnership with MOOCtracks 2
... Clinical Oncology (ASCO) today highlighted several studies in a ... posted online at www.asco.org in advance of ASCO,s 47th ... other major studies will be released in on-site press ... meeting, which is expected to draw approximately 30,000 cancer ...
... receives the Green Mark Platinum Award from the Building ... environmental sustainability. The highest award presented to selected organisations ... towards sustainability. The award goes to NTU,s School ... piece in the centre of the 200-hectare green campus ...
... , WEDNESDAY, May 18 (HealthDay News) -- New research finds ... cancer don,t reduce the average woman,s risk of dying from ... then a transvaginal ultrasound might even cause harm, the University ... of worrisome false-positive results, subsequent biopsies and resulting complications. ...
... of Pittsburgh School of Medicine have developed a mouse model ... rare genetic mutation that appears to cause MDD in the ... published online today in the American Journal of Medical ... clarify the brain events that lead to MDD, and contribute ...
... Reporter , WEDNESDAY, May 18 (HealthDay News) -- The ... the progression of eye problems in people with the ... says. Italian researchers report that they compared daily ... a placebo, and found that selenium could benefit people ...
... 18 (HealthDay News) -- The results of a first prostate-specific antigen ... can predict the risk of dying of prostate cancer within the ... Researchers analyzed blood samples collected from 12,090 Swedish men between 1974 ... nearly 5,000 of the men six years later when they were ...
Cached Medicine News:Health News:ASCO releases studies from upcoming annual meeting 2Health News:ASCO releases studies from upcoming annual meeting 3Health News:NTU wins Platinum Award from BCA for sustainable design 2Health News:Study Finds Ovarian Screening Tests Don't Improve Survival 2Health News:Pitt researchers build a better mouse model to study depression 2Health News:Selenium Might Help Treat Symptoms in Graves' Eye Disease 2Health News:Selenium Might Help Treat Symptoms in Graves' Eye Disease 3Health News:Earlier PSA Test Best Predicts Risk of Dying From Prostate Cancer: Study 2
(Date:9/3/2014)... ,    ... ~   Kiadis Pharma B.V. ... biopharmaceutical company developing T-cell immunotherapy treatments for blood cancers, ... , MD PhD, as its Chief Medical Officer. ... at Ceronco Biosciences. Prior to that he was VP ...
(Date:9/2/2014)... 2014 Reportbuyer.com has added a new ... Technologies for Molecular Imaging Devices ... The objectives of this study are to ... used for diagnostic purposes, present global market measurements ... market segments as well as forecast market and ...
(Date:9/2/2014)... -- Numotion is pleased to announce the appointment of Mark ... Mark is a 30-year retired veteran of GE where ... and was a GE Company Officer since 1999 and a ... running business units within GE Healthcare, with the most recent ... "We are delighted to welcome Mark to our Board," ...
Breaking Medicine Technology:Kiadis Pharma Appoints Jeroen Rovers as its Chief Medical Officer 2Kiadis Pharma Appoints Jeroen Rovers as its Chief Medical Officer 3Kiadis Pharma Appoints Jeroen Rovers as its Chief Medical Officer 4Kiadis Pharma Appoints Jeroen Rovers as its Chief Medical Officer 5Global Markets and Technologies for Molecular Imaging Devices 2Global Markets and Technologies for Molecular Imaging Devices 3Global Markets and Technologies for Molecular Imaging Devices 4Global Markets and Technologies for Molecular Imaging Devices 5Global Markets and Technologies for Molecular Imaging Devices 6Global Markets and Technologies for Molecular Imaging Devices 7Global Markets and Technologies for Molecular Imaging Devices 8Global Markets and Technologies for Molecular Imaging Devices 9Global Markets and Technologies for Molecular Imaging Devices 10Global Markets and Technologies for Molecular Imaging Devices 11Global Markets and Technologies for Molecular Imaging Devices 12Global Markets and Technologies for Molecular Imaging Devices 13Global Markets and Technologies for Molecular Imaging Devices 14Global Markets and Technologies for Molecular Imaging Devices 15Global Markets and Technologies for Molecular Imaging Devices 16Global Markets and Technologies for Molecular Imaging Devices 17Global Markets and Technologies for Molecular Imaging Devices 18Global Markets and Technologies for Molecular Imaging Devices 19Global Markets and Technologies for Molecular Imaging Devices 20Global Markets and Technologies for Molecular Imaging Devices 21Global Markets and Technologies for Molecular Imaging Devices 22Global Markets and Technologies for Molecular Imaging Devices 23Global Markets and Technologies for Molecular Imaging Devices 24Global Markets and Technologies for Molecular Imaging Devices 25
... Tenn., Nov. 18, 2011 MedSolutions , ... services, today announced the launch of its Implantable ... evidence-based guidelines to ensure the clinical appropriateness of ... With the cost of each ICD/CRT-D ...
... Md., Nov. 18, 2011 The U.S. Food and ... ) to treat patients with acute lymphoblastic leukemia (ALL), ... coli derived asparaginase and pegaspargase chemotherapy drugs used ... ) Acute lymphoblastic leukemia is a ...
Cached Medicine Technology:MedSolutions Launches Implantable Cardiac Defibrillator Program to Reduce Unnecessary Surgeries 2MedSolutions Launches Implantable Cardiac Defibrillator Program to Reduce Unnecessary Surgeries 3FDA Approves Erwinaze to Treat a Form of Leukemia 2FDA Approves Erwinaze to Treat a Form of Leukemia 3
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: